Ingmar Bruns - 06 Feb 2025 Form 4 Insider Report for Zentalis Pharmaceuticals, Inc. (ZNTL)

Signature
/s/ Andrea Paul, attorney-in-fact for Ingmar Bruns
Issuer symbol
ZNTL
Transactions as of
06 Feb 2025
Net transactions value
+$45,656
Form type
4
Filing time
12 Feb 2025, 17:00:31 UTC
Previous filing
05 Feb 2025
Next filing
09 Jan 2026

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZNTL Common Stock Purchase $45,656 +20,000 +120% $2.28 36,629 06 Feb 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.